Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris
ASAHI KAISEI CRP UNSP/ADR (AHKSY)
NASDAQ:AMEX Investor Relations:
asahi-kasei.co.jp/asahi/en/ir
Company Research
Source: Business Wire
Advancing Expansion in Severe Infectious Disease and Leveraging Existing Global Infrastructure to Drive Long-Term Growth CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Asahi Kasei announced it has entered into a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures AG, a German-based biopharmaceutical company, for approximately €780 million*. This transaction expands Asahi Kasei’s specialty pharmaceutical platform further into severe infectious diseases and is expected to close in the first quarter of fiscal 2026, subject to customary conditions.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226813309/en/Progress of Asahi Kasei business portfolio transformation.Asahi Kasei expects the acquisition to contribute positively to operating income after amortization of goodwill and other intangible assets from fiscal 2028 onward.The acquisition advances Asahi Kasei’s strategy to build a focused, sust
Show less
Read more
Impact Snapshot
Event Time:
AHKSY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AHKSY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AHKSY alerts
High impacting ASAHI KAISEI CRP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
AHKSY
News
- Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m [Yahoo! Finance]Yahoo! Finance
- Assessing Asahi Kasei (TSE:3407) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris [Yahoo! Finance]Yahoo! Finance
- Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases [Yahoo! Finance]Yahoo! Finance
- Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds [Yahoo! Finance]Yahoo! Finance